POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 69 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,292,649 | +44.0% | 543,130 | +6.5% | 0.00% | – |
| Q2 2023 | $897,528 | +180.8% | 509,959 | +391.4% | 0.00% | – |
| Q1 2023 | $319,603 | -29.4% | 103,767 | +21.4% | 0.00% | – |
| Q4 2022 | $452,970 | +96.1% | 85,466 | +31.1% | 0.00% | – |
| Q3 2022 | $231,000 | +79.1% | 65,168 | +29.7% | 0.00% | – |
| Q2 2022 | $129,000 | -88.0% | 50,246 | -79.0% | 0.00% | – |
| Q1 2022 | $1,072,000 | -37.5% | 239,289 | -5.0% | 0.00% | – |
| Q4 2021 | $1,715,000 | -8.5% | 251,793 | -2.0% | 0.00% | – |
| Q3 2021 | $1,874,000 | -23.7% | 257,061 | +4.9% | 0.00% | – |
| Q2 2021 | $2,456,000 | +55.4% | 245,069 | +48.1% | 0.00% | – |
| Q1 2021 | $1,580,000 | -11.2% | 165,425 | +2.0% | 0.00% | – |
| Q4 2020 | $1,780,000 | +19.7% | 162,195 | -3.2% | 0.00% | – |
| Q3 2020 | $1,487,000 | – | 167,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $9,254,000 | 2.96% |
| SECTORAL ASSET MANAGEMENT INC | 1,053,779 | $9,347,000 | 0.80% |
| Pentwater Capital Management LP | 4,879,490 | $43,281,000 | 0.56% |
| Vivo Capital, LLC | 926,449 | $8,218,000 | 0.48% |
| Boxer Capital, LLC | 1,251,055 | $11,097,000 | 0.38% |
| Ikarian Capital, LLC | 228,000 | $2,022,000 | 0.15% |
| Perceptive Advisors | 787,745 | $6,987,000 | 0.10% |
| Rock Springs Capital Management LP | 367,499 | $3,260,000 | 0.08% |
| PURA VIDA INVESTMENTS, LLC | 148,949 | $1,321,000 | 0.07% |
| PIPER SANDLER & CO. | 8,298 | $74,000 | 0.06% |